Home / Inspections / 1208393

FDA Inspection 1208393 — Hemagen Diagnostics Inc

Hemagen Diagnostics Inc — FEI 1181055

The FDA completed an inspection of Hemagen Diagnostics Inc on June 14, 2023 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 14, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Baltimore, MD (United States)

Facility

Other inspections at this facility

  • 1317040 (VAI Thu May 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1037233 (VAI Wed Jan 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 918077 (NAI Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 812190 (VAI Thu Dec 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 677299 (NAI Wed Aug 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources